HER2-positive breast cancer

Loibl, S; Gianni, L

Loibl, S (reprint author), GB Forsch GmbH, German Breast Grp, Martin Behaim Str 12, D-63263 Neu Isenburg, Germany.

LANCET, 2017; 389 (10087): 2415

Abstract

Anti-HER2 treatment for HER2-positive breast cancer has changed the natural biology of this disease. This Series article reviews the main achievements......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索